Obesity Congress | Nutrition Global Events | Conferences | Asia

Call for Abstract

Scientific Program

17^th World Congress on Obesity & Nutrition, will be organized around the theme “Exceeding the Vision towards Obesity and Nutrition”

World Obesity 2018 is comprised of 26 tracks and 228 sessions designed to offer comprehensive sessions that address current issues in World Obesity 2018.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Track 1:Obesity & Weight Management

Overweight and obesity are directly and indirectly linked to health and disease. Prevelance is expanding all over, particularly in western industrialized countries such as the UK, but also in countries undergoing rapid urbanization or 'westernization'. Overweight and obesity, and a static body mass index (BMI) commonly conceal sarcopenia (gain in body fat but loss of muscle mass and functional capacity) in older people, aggravated by inactivity

Steps to achieving a healthy weight:

Track 1-1Get organized!
Track 1-2Eat regular meals
Track 1-3Cut unhealthy fat from your diet
Track 1-4Cut out sugary drinks
Track 1-5Include physical activity in your daily routine
Track 1-6Eat a healthy diet
Track 1-7Make healthy fast-food, restaurant, and convenience-food choices to stay with your healthy eating when you eat out

Track 2:Obesity & Public Health

Obesity has become the public health issue of the day—and for good reason. The problem of excess weight gain and obesity is difficult for many scientists and doctors to understand because it seems a simple consequence of eating too much or doing too little. The remedy seems simple—to reduce intake or increase exercise. Awareness of the association of obesity with health problems is longstanding. Obesity prevention programs should be high on the scientific and political agenda in both industrialized and industrializing countries

Track 2-1Public health and the environment
Track 2-2An antiâ€obesity programme
Track 2-3Healthy Weight, Healthy Lives
Track 2-4Increase healthy habits
Track 2-5Eat a healthy diet

Track 3:Childhood Obesity

Childhood obesity is a serious health problem all over the world. Childhood obesity is a medical condition that affects children and teenagers. Everyone has a body shape that is just right for him or her changes but sometimes we can store excessive body fat. The efficiency of childhood obesity prevention programs can be seen by analyzing all interventional studies that intended to improve diet, physical activity, or both and that were conducted in schools, homes, primary care clinics, childcare settings, the community, or combinations of these settings in high-income countries.

Track 3-1Assessing Weight
Track 3-2Walking
Track 3-3Drinking water
Track 3-4Weight-loss surgery
Track 3-5Medications
Track 3-6Healthy eating
Track 3-7Treatment for obese children
Track 3-8Preventive measures in diet
Track 3-9Physical Activity Basics
Track 3-10Nutritional tips for Parents

Track 4:Genetic Obesity

Obesity observed in the entire family is considered to have genetic causes behind it. Such type of obesity is known as genetic obesity. For example, if grandparents or parents are obese the child can also become one. In this situation the child is facing genetic obesity. The lifestyle which the family shares is also responsible for this type of obesity. It can be caused due to unhealthy food habits common in the family. It may also depend on the eating habits of a particular region.

Track 4-1Have a balanced diet
Track 4-2Count calories
Track 4-3Keep track on weight
Track 4-4Mold your body with exercise and yoga
Track 4-5Avoid ignoring small things

Track 5:Obesity in Women

Obesity and Overweight negatively encounter the health of women in countless ways. Being overweight or obeseboost the relative risk of diabetes and coronary artery disease in women. Women who are obese have a higher risk of low back pain and knee osteoarthritis. Obesity negatively affects both contraception and fertility as well. Maternal obesity is related with leading standard of cesarean section as well as higher rates of high risk obstetrical conditions such as diabetes and hypertension. Pregnancy outcomes are negatively affected by maternal obesity (increased risk of neonatal mortality and malformations). Maternal obesity is lump together with a diminished intention to breastfeed, decreased initiation of breastfeeding, and decreased duration of breastfeeding. There seems to be an association between obesity and depression in women, though cultural factors may influence this association. Obese women are at higher risk for multiple cancers, including endometrial cancer, cervical cancer, breast cancer, and perhaps ovarian cancer.

Track 5-1Start with one small change
Track 5-2Switch out bad snacks for good snacks
Track 5-3Be realistic about which habits need to go
Track 5-4Find a healthy meal you like and eat it all the time
Track 5-5Move during your lunch break
Track 5-6Lift weights to lose weight
Track 5-7Schedule a weekly cheat meal

Track 6:Obesity Medicine

Obesity medication is the field of pharmaceutical devoted to the far-reaching consideration of patients with obese. It is the field of medicine committed to the absolute care of patients with obesity. Obesity Medicine target on health and disease, relating to the very broad spectrum of research in and strike on humans.Obesity medicine clinicians who are individuals from the Obesity Medicine Association use an exhaustive, logical, and individualized approach involved nutrition, physical activity, conduct treatment, and prescription to enable patients to get more fit and accomplish better general health.

Track 6-1Contrave (naltrexone HCl and bupropion HCl) ; Takeda Pharmaceuticals U.S.A.; For chronic weight management , Approved September 2014
Track 6-2Jardiance (empagliflozin) ; Boehringer Ingelheim; For the treatment of type II diabetes, Approved August 2014
Track 6-3Saxenda (liraglutide [rDNA origin] injection); Novo Nordisk; For chronic weight management, Approved December 2014
Track 6-4Tanzeum (albiglutide); GlaxoSmithKline; For the treatment of type II diabetes mellitus, Approved April 2014
Track 6-5Trulicity (dulaglutide); Eli Lilly; To improve glycemic control in type II diabetics, Approved September 2014
Track 6-6Nesina (alogliptin); Takeda; For the treatment of type II diabetes mellitus, Approved January 2013
Track 6-7Belviq (lorcaserin hydrochloride); Arena Pharmaceuticals; For the chronic management of weight loss, Approved June 2012
Track 6-8Bydureon (exenatide extended-release for injectable suspension); Amylin; For the improvement of glycemic control in adults with type II diabetes mellitus, Approved January 2012
Track 6-9Qsymia (phentermine + topiramate extended-release); Vivus; For the treatment of chronic weight management, Approved July 2012

Track 7:Obesity & Diabetes

Diabetes and obesity are chronic disorders that are on the rise worldwide. Body mass index has a strong relationship to diabetes and insulin resistance. In an obese individual, the amount of NEFA, glycerol, hormones, cytokines, proinflammatory substances, and other substances that are involved in the development of insulin resistance are increased. Insulin resistance with impairment of β-cell function leads to the development of diabetes. Gaining weight in early life is associated with the development of type 1 diabetes. NEFA is a cornerstone in the development of insulin resistance and in the impairment of β-cell function. New approaches in managing and preventing diabetes in obese individuals must be studied and investigated based on these facts